(Q54422031)

English

Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy.

scientific article

In more languages
default for all languages
No label defined

No description defined

Statements

Loss of ras oncogene mutation in a myelodysplastic syndrome after low-dose cytarabine therapy. (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit